Showing 1 - 10 of 61
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the industry has three strong pillars: very pro active...
Persistent link: https://www.econbiz.de/10005699264
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
A SWOT analysis of the Indian Pharmaceutical Industry (IPI) in the WTO regime reveals that the much acclaimed IPI’s expertise in process development skills were made possible by the amendments made to the Indian Patents Act 1970. This strength should be utilized maximum to benefit from...
Persistent link: https://www.econbiz.de/10005699186
This paper uses aggregate and firm level data to examine the characteristics of the Chinese pharmaceutical industry in general and its geographical agglomeration in particular. It addresses the following research questions: 1) Are there geographical agglomerations in China’s...
Persistent link: https://www.econbiz.de/10005341674
The political economy of the pharmaceutical industry defines truth significantly, if not substantially and wholly, in medicine as much as does dominant medical practice. This mediated wisdom of medicine is purveyed across populations through public health policies affecting millions as is seen...
Persistent link: https://www.econbiz.de/10005487672
Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...
Persistent link: https://www.econbiz.de/10005487733
Access to essential drugs is vital for the promotion of better health for the entire population. High prices of drugs are being used as an argument for greater government role in the drugs sector through effective regulation of the drug market. The high prices of drugs in the Philippines will...
Persistent link: https://www.econbiz.de/10004980026
There are many reports of ghost writings and ghost management of medical journal articles. Such articles are “ghostly†because signs of their actual production are largely invisible—academic authors whose names appear at the top of ghost-managed articles give corporate research...
Persistent link: https://www.econbiz.de/10005170183
The pharmaceutical industry is expanding worldwide. For some years now, it has been benefiting from the particular dynamics of the Asian economies as both purchasers and producers. It is not only the markets in China and India that register high growth rates. Despite the positive outlook India...
Persistent link: https://www.econbiz.de/10005170195